Drug
Kbsa301
Kbsa301: highest development phase Phase 1/2, developed by Aridis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Aridis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| KBSA301 NCT01589185 | Phase 1/2 | Pneumonia Due to Staphylococcus Aureus |
Latest
No recent events.
Follow Kbsa301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.